Table 3.
Clinical states causing excessive water loss
| Extrarenal water loss |
| Gastrointestinal losses |
| Vomiting |
| Nasogastric drainage |
| Ileostomy |
| Pancreatobiliary fistula |
| Diarrhea (non-secretory) |
| Laxatives, e.g., lactulose |
| Skin |
| Excessive sweating |
| Respiratory airways |
| Hyperpnea |
| Tracheal intubation |
| Mechanical ventilation |
| Excessive renal water losses |
| Osmotic (solute) diuresis |
| Osmotic diuretics, e.g., mannitol |
| Glucosuria, e.g., hyperglycemia, sodium-glucose transporter 2 (SGLT2) inhibitors |
| Urea diuresis, e.g., diuresis post-acute tubular necrosis, post- obstructive diuresis, use of catabolic medications (corticosteroids, tetracyclines, etc.), high protein intake, urea treatment for hyponatremia |
| Salt diuresis, e.g., intravenous infusion of saline, high salt intake |
| Water diuresis |
| Central diabetes insipidus |
| Idiopathic (most common) |
| Genetic: Familial (mutation causing misfolding of vasopressin), congenital hypopituitarism, Wolfram syndrome (diabetes insipidus, diabetes mellitus, optic atrophy, deafness) |
| Acquired: Neurosurgery, head trauma, brain tumors, infiltrative disorders (sarcoidosis, Langerhans cell histiocytosis, etc.) |
| Nephrogenic diabetes insipidus |
| Genetic: Inactivating mutations of V2 receptor gene (most common) or aquaporin 2 gene |
| Acquired: |
| Renal disease (chronic renal failure, post-acute tubular necrosis, obstructive nephropathy, sickle cell disease, autosomal dominant polycystic kidney disease) |
| Electrolyte disorders: Hypokalemia, hypercalcemia |
| Drugs: Lithium, amphotericin, demeclocycline, ifosfamide, V2 receptor antagonists |
| Gestation: Increased placental production of vasopressinase |
| Upward resetting of the osmostat (reset osmostat): Primary hyperaldosteronism (thought to be secondary to volume expansion and resulting in modest hypernatremia, up to 147 mmol/L) |